# Alain Horvais

> Alain Horvais is a seed investor at Kurma Partners backing Health Care and Health Diagnostics. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Kurma Partners](https://shizune.co/investors/profile/kurma-life-science-partners)
- Location: Paris, France
- Total investments: 3
- Last investment: Sep 2023
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/alain-horvais-339131/

Alain Horvais is a seed investor at Kurma Partners in Paris focused on Health Care and Health Diagnostics. Alain Horvais is based out of Paris, Ile-de-France and is the partner of Kurma Partners. Alain previously worked at AstraZeneca as a diagnostic team director. Alain Horvais attended the NEOMA Business School.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Health Diagnostics | 2 | 67% |
| Therapeutics | 1 | 33% |
| Biotechnology | 1 | 33% |
| Medical Device | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 67% |
| Funding Round | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 1 | 33% |
| Belgium | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Axithra | Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood. | $10.7M | Seed | Sep 05, 2023 |  |
| SmartCatch | SmartCatch brings value-added liquid biopsy technology to empower clinicians, researchers, and industry in the fight against cancer. | $3.5M |  | May 17, 2021 |  |
| SmartCatch | SmartCatch brings value-added liquid biopsy technology to empower clinicians, researchers, and industry in the fight against cancer. | $3.9M | Seed | May 17, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [IRDI](https://shizune.co/investors/profile/irdi-midi-pyrenees) — VC Fund, 2 deals together
- [M Capital Partners](https://shizune.co/investors/profile/m-capital-partners) — VC Fund, 2 deals together
- [Hamamatsu Photonics](https://shizune.co/investors/profile/hamamatsu-photonics) — VC Fund, 1 deal together
- [imec.xpand](https://shizune.co/investors/profile/imec-xpand) — VC Fund, 1 deal together
- [Meusinvest (Noshaq)](https://shizune.co/investors/profile/meusinvest) — VC Fund, 1 deal together
- [Qbic](https://shizune.co/investors/profile/qbic) — VC Fund, 1 deal together

## About Kurma Partners

VC Fund · Paris, France

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

5 contacts available at Kurma Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Alain Horvais | Partner | https://shizune.co/investors/profile/alain-horvais |
| Amanda Gett Chaperot | Partner | https://shizune.co/investors/profile/amanda-gett |
| Amine Marouf | Principal | https://shizune.co/investors/profile/amine-marouf |
| Peter Neubeck | Partner | https://shizune.co/investors/profile/peter-neubeck |
| Philippe Peltier | Partner | https://shizune.co/investors/profile/philippe-peltier |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Alain Horvais invest in?

Alain Horvais invests primarily in Health Care, Health Diagnostics and Therapeutics startups, most often at Seed and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Alain Horvais last invest?

The most recent investment recorded for Alain Horvais closed in Sep 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co